B+
Bull case
25%
Probability
Target price
$114.38
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
CVS
CVS HealthANYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$106.65
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$89.40
Analysis reference price unavailable
Analysis 2026-08-17 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-17
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+76.1
Score
AI commentary
News tone is mixed: primary-company filings show a strong Q2 beat and guidance raise, while stored secondary coverage describes investor concern about sustainability and an adverse post-print reaction. Social sentiment, options skew, short interest, employee sentiment, and analyst revision data are unavailable; zero values indicate unavailable rather than neutral measured sentiment.
RankAlpha Sentiment Codex - 2026-08-17
Open full AI memoEvidence flagged
peer set is too generic or lacks enough direct operating comparators
Impact
tentative
Confidence
-
AI events
2026-08-05eventQ2 beat and FY26 guidance raiseMedium impact
CVS reported Q2 revenue of $106.1 billion and adjusted EPS of $2.58, and raised FY26 adjusted EPS guidance to $7.90-$8.10 and operating-cash-flow guidance to at least $11.5 billion [#SEC-8K-2026-08-05].
2026-12-31catalystAetna margin recovery executionHigh impact
Health Care Benefits margin recovery was a primary driver of Q2 adjusted EPS growth, while adjusted operating income increased across all segments. Sustained execution could support a higher 2026 earnings base [#SEC-8K-2026-08-05].
2027-01-01catalyst2027 PBM and medical-cost pressureHigh impact
Stored earnings context cites ongoing 340B pressure, normalization of Rite Aid script-share gains, potential lower Caremark membership, and rising second-half medical costs as risks to the durability of the recovery [#PR-EARNINGS-2026-08-14].
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-17 • Updated nightlySource: Internal modelMethodology